UK markets closed

Valeo Pharma Inc. (VP2.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.0390-0.0035 (-8.24%)
At close: 08:18AM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 6.36M
Enterprise value 44.44M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.09
Price/book (mrq)N/A
Enterprise value/revenue 2.08
Enterprise value/EBITDA -3.04

Trading information

Stock price history

Beta (5Y monthly) 2.59
52-week change 3-84.60%
S&P500 52-week change 326.27%
52-week high 30.2940
52-week low 30.0325
50-day moving average 30.0840
200-day moving average 30.1221

Share statistics

Avg vol (3-month) 3211
Avg vol (10-day) 3290
Shares outstanding 598.66M
Implied shares outstanding 6162.98M
Float 845.29M
% held by insiders 147.12%
% held by institutions 17.24%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CAD.

Fiscal year

Fiscal year ends 31 Oct 2023
Most-recent quarter (mrq)31 Jan 2024

Profitability

Profit margin -52.37%
Operating margin (ttm)-35.92%

Management effectiveness

Return on assets (ttm)-23.07%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)54.29M
Revenue per share (ttm)0.62
Quarterly revenue growth (yoy)2.90%
Gross profit (ttm)N/A
EBITDA -14.09M
Net income avi to common (ttm)-28.43M
Diluted EPS (ttm)-0.2200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)9.59M
Total cash per share (mrq)0.1
Total debt (mrq)66.36M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.49
Book value per share (mrq)-0.48

Cash flow statement

Operating cash flow (ttm)-2.97M
Levered free cash flow (ttm)-5.8M